Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

Clinical trial NCT01995578 · COMPLETED

Trial details

NCT number

NCT01995578

Sponsor

Memorial Sloan Kettering Cancer Center

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2013-12-01

Primary completion

2023-09-27

Enrollment

32

View on ClinicalTrials.gov